Shaping Treatment Expectation to Optimize Efficacy of Interleukin 17A Antagonist Secukinumab in Psoriasis Patients

Shaping Treatment Expectation to Optimize Efficacy of Interleukin 17A Antagonist Secukinumab in Psoriasis Patients

Stefanie Hölsken,1 Frederik Krefting,2 Senta Mühlhaus,2 Daniela Bese,2 Manfred Schedlowski,1,3 Wiebke Sondermann2 1Institute of Medical Psychology and Behavioral Immunobiology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany; 2Department of Dermatology, Venereology and Allerg...

Full description

Saved in:
Bibliographic Details
Main Authors: Hölsken S, Krefting F, Mühlhaus S, Bese D, Schedlowski M, Sondermann W
Format: Article
Language:English
Published: Dove Medical Press 2025-01-01
Series:Psoriasis: Targets and Therapy
Subjects:
psoriasis treatment
psychodermatology
placebo effect
Online Access:https://www.dovepress.com/shaping-treatment-expectation-to-optimize-efficacy-of-interleukin-17a--peer-reviewed-fulltext-article-PTT
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.dovepress.com/shaping-treatment-expectation-to-optimize-efficacy-of-interleukin-17a--peer-reviewed-fulltext-article-PTT

Similar Items